药讯速递

Module Load Warning
One or more of the modules on this page did not load. This may be temporary. Please refresh the page (click F5 in most browsers). If the problem persists, please let the know.

[栏目介绍]

标题

时间

阅读
数量

评论
数量

denosumab在晚期乳腺癌患者中显现5个月的治疗优势
Denosumab Update Shows 5-Month Advantage in Advanced Breast ...

2010-12-15

曲妥珠单抗/帕妥珠单抗二联疗法可根治某些早期乳腺癌
Trastuzumab/Pertuzumab Doublet Eradicates Some Early Breast ...

2010-12-14

EMA加大信息透明度，将公开所有不良反应资料
EMA Prepares for Data-Request Blitz; All Adverse Reaction In...

2010-12-13

Xgeva获准用于预防实体瘤骨转移患者的骨骼相关事件
Xgeva approved for prevention of skeletal-related events in ...

2010-11-23

130

中国医改能给创新药带来更高的回报吗？
Will China Healthcare Reform Drive Higher Rewards For Innova...

2010-11-23

154

新型化疗药获准用于晚期乳腺癌
New chemotherapeutic agent approved for use in late-stage br...

2010-11-17

102

礼来凭借在上海新建的研发中心转变在华发展模式
Lilly Shifts Gears In China With New Shanghai-based R&D Cent...

2010-11-09

202

Aurora A激酶抑制剂对卵巢癌有效
Aurora A Kinase Inhibitor Active in Ovarian Cancer

2010-10-28

Afatinib未能改善非小细胞肺癌患者的总体生存状况
Overall Survival Advantage Eludes Afatinib in NSCLC

2010-10-22

184

PARP抑制剂可使乳腺癌生存延长近5个月
PARP Inhibitor Adds Nearly 5 Months to Breast Cancer Surviva...

2010-10-15

222

乳腺癌随机试验早期结果支持应用曲妥珠单抗-DM1
Early Results Favor Trastuzumab-DM1 in Randomized Breast Can...

2010-10-11

178

NICE转变态度支持赫赛汀用于亚组胃癌患者
NICE, In A Reversal, Endorses Use of Herceptin In A Subset o...

2010-10-05

183

2种抗基底细胞癌药物前景看好
Two Promising Drugs Identified for Basal Cell Carcinomas

2010-09-14

180

可为转移性黑色素瘤个体化治疗提供新方案
PLX4032 May Clear Path for Individualized Treatment of Metas...

2010-08-20

NICE批准通过3种抗癌药
NICE Says Yes to Three Cancer Drugs

2010-08-03

195

用于诊断前列腺癌和其他癌症的新型血液分子检测即将投入使用
Novel Molecular Blood Test for Prostate, Other Cancer Diagno...

2010-07-27

224

BATTLE 活检数据阐明了肺癌对化疗耐药的原因
BATTLE Biopsy Data Shed Light on Cause of Chemoresistant Lun...

2010-07-26

185

AMG 386为卵巢癌患者抗血管生成治疗指明新方向
AMG 386 Takes Antiangiogenesis Therapy in New Direction for ...

2010-07-16

413

凡德他尼可延缓甲状腺髓样癌进展
Vandetanib Stalls Progression of Metastatic Medullary Thyroi...

2010-07-15

191

NICE拒绝接受米伐木肽和贝伐单抗
NICE Rejects Mifamurtide, Bevacizumab

2010-07-15

135

[栏目介绍]

标题

时间

阅读
数量

评论
数量

培美曲塞维持治疗提高肺癌患者的存活率
Pemetrexed Maintenance Improves Lung Cancer Survival

2009-09-22

1462

卡铂+聚乙二醇脂质体阿霉素治疗复发性卵巢癌等效于卡铂+紫杉醇
Carboplatin/Pegylated Liposomal Doxorubicin as Effective as ...

2009-07-13

1161

美国FDA批准首个晚期肺癌维持治疗用药
U.S. Approves First Maintenance Treatment for Advanced Lung ...

2009-07-08

793

美国FDA扩大放免治疗制剂Zevalin治疗非霍奇金淋巴瘤的...
Use of radioimmunotherapy agent Zevalin expanded in non-Hodg...

2009-09-10

748

Zodiac临床研究：口服vandetanib可延迟晚期非小...
Oral Vandetanib Delays Recurrence in Advanced NSCLC Zodiac T...

2009-06-09

740

抗血管新生药阿瓦斯汀现已获准用于治疗转移性肾细胞癌
Antiangiogenesis drug Avastin now approved for metastatic re...

2009-08-11

655

射频消融治疗可阻止不可切除肝转移性结直肠癌疾病的进展
Radiofrequency Ablation Averts Progression in Unresectable C...

2009-04-02

610

Olaparib可安全用于BRCA相关肿瘤的治疗
Olaparib Safe Against BRCA-Associated Cancers

2009-06-24

609

辉瑞、礼来和默克在亚洲启动癌症研究合作项目
Pfizer, Lilly And Merck Strike Up Cancer Research Partnershi...

2010-02-25

609

FDA批准Votrient用于治疗晚期肾细胞癌
FDA approves Votrient for advanced renal cell carcinoma

2009-10-23

599

单克隆抗体Arzerra获准用于难治性慢性淋巴细胞白血病
Monoclonal antibody Arzerra approved for refractory chronic ...

2009-10-29

569

Istodax获准用于治疗皮肤T细胞淋巴瘤
Istodax approved for cutaneous T-cell lymphoma

2009-11-16

559

研究二甲双胍用于抗癌治疗的可能性
Metformin Being Investigated as Possible Anticancer Treatmen...

2009-10-01

541

免疫治疗药Provenge获准用于治疗某些前列腺癌
Immunotherapy agent Provenge approved for certain prostate c...

2010-05-13

529

09年NIH向医疗器械有效性比较研究累计拨款达4,000万美...
Device Comparative Effectiveness Studies Received $40 Mil. F...

2010-01-11

523

用于复发性或难治性外周T细胞淋巴瘤的新制剂获批
New agent for relapsed or refractory peripheral T-cell lymph...

2009-10-10

517

罕用药物可有效治疗高强度预处理的多发性骨髓瘤
Orphan Drug Active in Heavily Pretreated Multiple Myeloma

2009-06-30

501

食品与药品管理局专家小组一致推荐使用阿伐他汀治疗脑肿瘤
U.S. Panel Unanimously Recommends Brain Tumor Approval for A...

2009-03-31

481

抗癌药Alimta现已获准用作非鳞状细胞NSCLC的维持治疗...
Cancer drug Alimta now approved as maintenance therapy for n...

2009-07-10

472

在一线化疗方案中加入西妥昔单抗可阻止结肠癌的进展
Adding Cetuximab to First-Line Chemotherapy Cuts Colon Cance...

2009-04-01

467

[栏目介绍]

标题

时间

阅读
数量

评论
数量

卡铂+聚乙二醇脂质体阿霉素治疗复发性卵巢癌等效于卡铂+紫杉醇
Carboplatin/Pegylated Liposomal Doxorubicin as Effective as ...

2009-07-13

1161

PARP抑制剂可使乳腺癌生存延长近5个月
PARP Inhibitor Adds Nearly 5 Months to Breast Cancer Surviva...

2010-10-15

222

中国医改能给创新药带来更高的回报吗？
Will China Healthcare Reform Drive Higher Rewards For Innova...

2010-11-23

154

EMA加大信息透明度，将公开所有不良反应资料
EMA Prepares for Data-Request Blitz; All Adverse Reaction In...

2010-12-13

曲妥珠单抗/帕妥珠单抗二联疗法可根治某些早期乳腺癌
Trastuzumab/Pertuzumab Doublet Eradicates Some Early Breast ...

2010-12-14

denosumab在晚期乳腺癌患者中显现5个月的治疗优势
Denosumab Update Shows 5-Month Advantage in Advanced Breast ...

2010-12-15

Afatinib未能改善非小细胞肺癌患者的总体生存状况
Overall Survival Advantage Eludes Afatinib in NSCLC

2010-10-22

184

Aurora A激酶抑制剂对卵巢癌有效
Aurora A Kinase Inhibitor Active in Ovarian Cancer

2010-10-28

礼来凭借在上海新建的研发中心转变在华发展模式
Lilly Shifts Gears In China With New Shanghai-based R&D Cent...

2010-11-09

202

新型化疗药获准用于晚期乳腺癌
New chemotherapeutic agent approved for use in late-stage br...

2010-11-17

102

Xgeva获准用于预防实体瘤骨转移患者的骨骼相关事件
Xgeva approved for prevention of skeletal-related events in ...

2010-11-23

130

FDA批准新的治疗晚期前列腺癌药物
Drug for patients with advanced prostate cancer approved by ...

2009-01-06

371

在一线化疗方案中加入西妥昔单抗可阻止结肠癌的进展
Adding Cetuximab to First-Line Chemotherapy Cuts Colon Cance...

2009-04-01

467

射频消融治疗可阻止不可切除肝转移性结直肠癌疾病的进展
Radiofrequency Ablation Averts Progression in Unresectable C...

2009-04-02

610

Avastin获批用于治疗胶质母细胞瘤
Avastin now approved for use in patients with glioblastoma

2009-06-12

420

食品与药品管理局专家小组一致推荐使用阿伐他汀治疗脑肿瘤
U.S. Panel Unanimously Recommends Brain Tumor Approval for A...

2009-03-31

481

Zodiac临床研究：口服vandetanib可延迟晚期非小...
Oral Vandetanib Delays Recurrence in Advanced NSCLC Zodiac T...

2009-06-09

740

多肽疫苗能显著提高转移性黑色素瘤治疗反应性
Peptide Vaccine Significantly Improves Response in Metastati...

2009-06-11

244

交替治疗方案的次序不影响转移性乳腺癌患者的生存率
Order of Crossover Regimen Does Not Affect Survival in Metas...

2009-06-22

437

Olaparib可安全用于BRCA相关肿瘤的治疗
Olaparib Safe Against BRCA-Associated Cancers

2009-06-24

609

肿瘤学

病例分析

反复腹胀伴纳差、乏力3月余——上海中山医院病例

复旦大学附属中山医院消化科梁晓燕涂传涛

患者，女性，46岁，因“反复腹胀伴纳差、乏力3月余” 于2010年8月12日入院。患者3个月前开始无明显诱因下出现反复腹胀，伴纳差、乏力、反酸、嗳气，胸骨后有不适感，反复恶心、呕吐，呕吐物多为宿食，不含咖啡样物，不含鲜血，呕吐后腹胀症状可稍缓解，但随着进食又出现上述症状，一般1~2天呕吐1次。大便次数少，开始时10余天1次大便，使用开塞露后可3~4天1次大便，大便性状正常，无里急后重及黏液脓血便，无腹痛及黑便。

医学数据库